Bgm (BGM) Shares Outstanding (2019 - 2025)
Bgm (BGM) posted quarterly Shares Outstanding (Entity) of $566.3 million for Q3 2025, up 1467.31% year-over-year from $36.1 million in Q3 2024, and up 258.25% quarter-over-quarter from $158.1 million in Q1 2025.
Bgm (BGM) Shares Outstanding (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Shares Outstanding (Entity) for 7 consecutive years, with $566.3 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Shares Outstanding (Entity) rose 1467.31% year-over-year to $566.3 million; the TTM figure through Sep 2025 stood at $566.3 million (up 1467.31% YoY), while the FY2025 annual figure was $566.3 million, up 1467.31% from the prior year.
- Shares Outstanding (Entity) rose to $566.3 million in Q3 2025 per BGM's latest filing, from $158.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $566.3 million in Q3 2025 and bottomed at $3.9 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $84.1 million across 5 years, with a median of $21.4 million in 2022.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) changed 0.0% — and 2025, when it surged 1467.31%.
- Bgm's Shares Outstanding (Entity) stood at $4.1 million in 2021, then rose by 4.87% to $4.3 million in 2022, then changed by 0.0% to $4.3 million in 2023, then jumped by 742.25% to $36.1 million in 2024, then soared by 1467.31% to $566.3 million in 2025.
- Business Quant data shows BGM's Shares Outstanding (Entity) at $566.3 million in Q3 2025, $158.1 million in Q1 2025, and $36.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Bgm | 29.92 Mn | 20.10 Mn | - | 113.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 113.26 Mn |
| Mar 31, 2025 | 31.62 Mn |
| Sep 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 35.75 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 35.75 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 35.75 Mn |
| Sep 30, 2021 | 6.82 Mn |
| Mar 31, 2021 | 6.49 Mn |
| Sep 30, 2020 | 6.00 Mn |
| Sep 30, 2019 | 6.00 Mn |